Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JG.3.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JG.3.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JG.3.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HK.27.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.27.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.27.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.27.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HV.1.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HV.1.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HV.1.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HV.1.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GK.1.11ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GK.1.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.1.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.1.11NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GK.8.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GK.8.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.8.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.8.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GK.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GK.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XEORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XEENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XEENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XENUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XCVORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XCVENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XCVENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XCVNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.31.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.31.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.31.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.31.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.50ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.50ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.50ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.50NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.78ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.78ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.78ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.78NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.43ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.43ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.43ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.43NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HR.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HR.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HR.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used